Clues to Reshaping Anti-alpha-Synuclein Immunotherapy in Early Parkinson's Disease Patients. Palermo G, Ceravolo R. Mov Disord 2022 Dec 15. doi: 10.1002/mds.29294.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Palermo G, Ceravolo R. Clues to Reshaping Anti-alpha-Synuclein Immunotherapy in Early Parkinson's Disease Patients. Mov Disord 2022 Dec 15. doi: 10.1002/mds.29294.
PMID: 36519627